Skip to main content
NC

Native Cardio, Inc.

Native Cardio develops a minimally invasive medical device specifically designed to treat postoperative atrial fibrillation (POAF), a common complication affecting up to 60% of cardiac surgery patients. By providing an alternative to traditional intravenous antiarrhythmic drugs and external cardioversion, the device aims to reduce the risk of serious side effects and improve patient outcomes.

Founded 2018200+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • Native Cardio develops a minimally invasive medical device specifically designed to treat postoperative atrial fibrillation (POAF), a common complication affecting up to 60% of cardiac surgery patients. By providing an alternative to traditional intravenous antiarrhythmic drugs and external cardioversion, the device aims to reduce the risk of serious side effects and improve patient outcomes.
This profile is AI-generated and may contain inaccuracies.